ZNTL
#3255
Zentalis Pharmaceuticals, Inc. - common stock
4.7 7 USD
+0.03%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+3.25%
Monthly Change
+22.94%
6 month change
+36.29%
Year Change
+248.18%
Previous Close
4.6 2
Open
4.6 3
Low
4.6 2
High
4.7 9
Volume
596
Financials
- Market Capitalization 339.56 M
- Employee 106
- Founded 2014
- CEO N/A
- Website www.zentalis.com
- Headquarter California, United States
- FIGI BBG00R2K8TF5
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.71
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3229 |  IMRX Immuneering Corporation - Class A Common Stock | 5.23 USD | +1.36% | +2.55% | +22.20% | +24.82% | 338.37 M USD | ||
| 3241 |  PALI Palisade Bio, Inc. - Common Stock | 1.93 USD | +2.12% | -7.21% | +11.56% | +13.53% | 335.01 M USD | ||
| 3294 |  LYEL Lyell Immunopharma, Inc. - Common Stock | 13.41 USD | -6.42% | -15.71% | -2.69% | -44.56% | 312.91 M USD | ||
| 3299 |  FHTX Foghorn Therapeutics Inc. - Common Stock | 5.38 USD | -1.10% | -10.33% | +26.89% | +31.86% | 315.88 M USD |
Frequently asked questions about Zentalis Pharmaceuticals, Inc. - common stock
What is the Zentalis Pharmaceuticals, Inc. - common stock stock price today?
The current price of Zentalis Pharmaceuticals, Inc. - common stock (ZNTL) is 4.77. Over the past 24 hours, the stock has changed by +3.25%. Follow the ZNTL chart for real-time price dynamics.
What is the stock ticker of Zentalis Pharmaceuticals, Inc. - common stock?
Zentalis Pharmaceuticals, Inc. - common stock trades under the ticker ZNTL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Zentalis Pharmaceuticals, Inc. - common stock stock going up?
ZNTL has changed by -0.21% over the last week, +22.94% over the last month, and +248.18% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Zentalis Pharmaceuticals, Inc. - common stock net income for the last quarter?
Zentalis Pharmaceuticals, Inc. - common stock reported net income of -35.35 M for the last quarter. The previous quarter showed -35.22 M, which means net income changed by -0.39%.
How many employees does Zentalis Pharmaceuticals, Inc. - common stock have?
As of the latest available data, Zentalis Pharmaceuticals, Inc. - common stock has 106 employees. Workforce size can provide additional context about the company's scale and operations.
What is Zentalis Pharmaceuticals, Inc. - common stock EBITDA?
Zentalis Pharmaceuticals, Inc. - common stock EBITDA is -37.3 M, and its EBITDA margin is -9 326%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Zentalis Pharmaceuticals, Inc. - common stock stock?
You can buy Zentalis Pharmaceuticals, Inc. - common stock (ZNTL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Zentalis Pharmaceuticals, Inc. - common stock stock?
Investing in Zentalis Pharmaceuticals, Inc. - common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ZNTL chart and related analysis on metatrader.com as part of your research.